Atlanta Vanguard Medical Associates Pc | |
3692 Highlands Pkwy Se Smyrna GA 30082-5184 | |
(678) 305-1700 | |
(678) 766-1744 |
Full Name | Atlanta Vanguard Medical Associates Pc |
---|---|
Speciality | Internal Medicine |
Location | 3692 Highlands Pkwy Se, Smyrna, Georgia |
Authorized Official Name and Position | Michael T. Morris (OWNER) |
Authorized Official Contact | 6783051700 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Atlanta Vanguard Medical Associates Pc 3692 Highlands Pkwy Se Smyrna GA 30082-5184 Ph: (678) 305-1700 | Atlanta Vanguard Medical Associates Pc 3692 Highlands Pkwy Se Smyrna GA 30082-5184 Ph: (678) 305-1700 |
NPI Number | 1164773164 |
---|---|
Provider Enumeration Date | 10/01/2012 |
Last Update Date | 01/25/2013 |
Medicare PECOS PAC ID | 7810148368 |
---|---|
Medicare Enrollment ID | O20121112000045 |
News Archive
A new study of more than 150 COVID-19 patients shows that IgA antibodies dominate the early response to the SARS-CoV-2 virus, coming on more quickly and strongly than IgG and IgM antibodies. This is a somewhat unexpected result, as IgM antibodies are usually the immune system's first responders.
Neogen Corporation announced today that it has acquired the stock of Chem-Tech Ltd., a manufacturer of insecticides for the animal and food industries. The 35-year-old company, which is wholly owned by Pat and Kelle Rolfes, operates an extensive manufacturing and distribution facility in Pleasantville, Iowa.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
Today's news pages are full of stories detailing more particulars of the new health care bill to be signed into law today by President Obama. Meanwhile, the headlines also indicate that for Democrats, politically capitalizing on the new measure will be no easy task.
› Verified 2 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1164773164 | NPI | - | NPPES |
003129899A | Medicaid | GA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | (Georgia) | Secondary |
207RC0000X | Internal Medicine - Cardiovascular Disease | (Georgia) | Primary |
Provider Name | Michael T Morris |
---|---|
Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
Provider Identifiers | NPI Number: 1245409101 PECOS PAC ID: 2567534654 Enrollment ID: I20080707000486 |
News Archive
A new study of more than 150 COVID-19 patients shows that IgA antibodies dominate the early response to the SARS-CoV-2 virus, coming on more quickly and strongly than IgG and IgM antibodies. This is a somewhat unexpected result, as IgM antibodies are usually the immune system's first responders.
Neogen Corporation announced today that it has acquired the stock of Chem-Tech Ltd., a manufacturer of insecticides for the animal and food industries. The 35-year-old company, which is wholly owned by Pat and Kelle Rolfes, operates an extensive manufacturing and distribution facility in Pleasantville, Iowa.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
Today's news pages are full of stories detailing more particulars of the new health care bill to be signed into law today by President Obama. Meanwhile, the headlines also indicate that for Democrats, politically capitalizing on the new measure will be no easy task.
› Verified 2 days ago
Provider Name | Faye Vargas Morris |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1194707398 PECOS PAC ID: 9830186279 Enrollment ID: I20090211000768 |
News Archive
A new study of more than 150 COVID-19 patients shows that IgA antibodies dominate the early response to the SARS-CoV-2 virus, coming on more quickly and strongly than IgG and IgM antibodies. This is a somewhat unexpected result, as IgM antibodies are usually the immune system's first responders.
Neogen Corporation announced today that it has acquired the stock of Chem-Tech Ltd., a manufacturer of insecticides for the animal and food industries. The 35-year-old company, which is wholly owned by Pat and Kelle Rolfes, operates an extensive manufacturing and distribution facility in Pleasantville, Iowa.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
Today's news pages are full of stories detailing more particulars of the new health care bill to be signed into law today by President Obama. Meanwhile, the headlines also indicate that for Democrats, politically capitalizing on the new measure will be no easy task.
› Verified 2 days ago
News Archive
A new study of more than 150 COVID-19 patients shows that IgA antibodies dominate the early response to the SARS-CoV-2 virus, coming on more quickly and strongly than IgG and IgM antibodies. This is a somewhat unexpected result, as IgM antibodies are usually the immune system's first responders.
Neogen Corporation announced today that it has acquired the stock of Chem-Tech Ltd., a manufacturer of insecticides for the animal and food industries. The 35-year-old company, which is wholly owned by Pat and Kelle Rolfes, operates an extensive manufacturing and distribution facility in Pleasantville, Iowa.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
Today's news pages are full of stories detailing more particulars of the new health care bill to be signed into law today by President Obama. Meanwhile, the headlines also indicate that for Democrats, politically capitalizing on the new measure will be no easy task.
› Verified 2 days ago
St Paul Medical Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3001 S Cobb Dr Se, Suite 205, Smyrna, GA 30080 Phone: 404-731-2931 | |
Mpm Group Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2430 Herodian Way Se Ste 210, Smyrna, GA 30080 Phone: 770-933-9951 | |
Cumberland Ridge Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1314 Concord Rd Se, Smyrna, GA 30080 Phone: 770-333-8889 Fax: 770-333-8948 | |
Allcare Health Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2220 Atlanta Rd Se, Smyrna, GA 30080 Phone: 770-970-0024 | |
Mariposa Medical Associates, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 767 Concord Rd Se, Smyrna, GA 30082 Phone: 678-305-1700 | |
Clinica De La Salud Hispana Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 969 Windy Hill Rd Se, Suite E, Smyrna, GA 30080 Phone: 678-888-0173 Fax: 678-888-0177 | |
Genesis Healthcare Associates Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3200 Highlands Parkway, Suite 250, Smyrna, GA 30082 Phone: 770-434-1662 Fax: 770-434-1304 |